Featured Product
This Week in Quality Digest Live
Quality Insider Features
Hari Polu
Ensure the reliability of electronic devices by testing specialty metals and materials
Knowledge at Wharton
Six steps that can transform team and organizational performance
Dylan Walsh
Performance measures drive incentives, and incentives drive behavior
Phanish Puranam
Take the Bionic Readiness Survey and help answer that question

More Features

Quality Insider News
More than half of respondents expect to meet Industry 4.0 goals within two years
Get set and go with automated laser marking for streamlined production
Features 640 watts of Blackstone-NEY single or multi-frequency ultrasonics
New functions for blending, tapering, offsetting, hollowing, and thickening mixed models.
Counters and linear gages enable real-time measurement and data management in any type of work environment
Both quality professionals and their business leaders agree that openness and communication is essential to moving forward
Creaform has optimized its fully integrated 3D software platform that powers the entire fleet of 3D scanning and measurement technologies
Greenlight Guru and MedCrypt partner to secure medical devices
Measures EV rotor shafts and cylindrical components

More News

Quality Digest

Quality Insider

New Standard to Help Diagnose Heart Attacks

Published: Sunday, May 23, 2004 - 22:00

Diagnosing heart attacks may become an even more precise science with the advent of the first of a series of new clinical standards issued by the National Institute of Standards and Technology.

Standard Reference Material 2921--human cardiac troponin complex--is intended to help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.

The SRM is a solution containing certified concentrations of three related proteins including cardiac troponin I, purified from human heart tissue from cadavers. Users can calibrate their assays by analyzing the SRM and comparing the results to the NIST-certified value for troponin I. The standard is expected to help reduce variations in clinical test results from as much as 50-fold on the same sample to twofold. "It’s a big first step toward getting the system under control," says Michael Welch, leader of the NIST development team.

Although NIST already produces more than 60 SRMs for the clinical diagnostics community, this is the first designed to help measure concentrations of large, protein-based health status markers. Troponin I is difficult to measure because it can exist in low concentrations and in different chemical forms, sometimes attached to other related proteins. NIST is developing additional standards and methods for measuring other health-status indicators of this type, including hormones used to assess thyroid function and other markers for heart attack risk.

SRM 2921 is intended to help U.S. makers of in vitro diagnostic medical devices sell their products in Europe. A European Union directive requires that such devices be calibrated with standards that are traceable to internationally recognized certified reference materials or procedures. SRM 2921 has been nominated for inclusion on the international list of higher-order reference materials. The list currently contains approximately 150 entries for 96 health status markers; NIST SRMs provide traceability for 72 of these.

For more information, click here.

Discuss

About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.